Feasibility of ultrasound‑guided axillary vein access for implantation of cardiac implantable electronic device leads
10.1186/s42444-024-00125-6
- Author:
Seongtaek OH
1
;
Jongmin HWANG
;
Hyoung‑Seob PARK
;
Tae‑Wan CHUNG
;
Minsu JUNG
Author Information
1. Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, 1035 Dalgubeol‑daero, Dalseo‑gu, Daegu 42601, Republic of Korea
- Publication Type:RESEARCH
- From:International Journal of Arrhythmia
2024;25(3):19-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:The axillary vein is preferred over the subclavian vein, and the cephalic vein for cardiac implantable electronic device (CIED) lead insertion. However, studies on ultrasound-guided axillary vein access (US-AVA) in Asia are scarce. This study aims to evaluate the feasibility of US-AVA for CIED lead implantation in Korean patients.
Methods:From September 2021 to September 2023, we employed US-AVA for CIED lead implantation procedures. Patients’ demographic and procedural data were collected and analyzed retrospectively.
Results:US-AVA was successful in 301 patients (97.7%). There were no occurrences of pneumothorax or severe hematoma due to inadvertent arterial puncture, nor were there any other significant vascular access-related acute complications. During the median 1.7 years of follow-up, no CIED infection or lead-related problems have occurred. Compared to a historical cohort of patients who underwent fluoroscopy-guided axillary vein access (FL-AVA), US-AVA significantly reduced procedure and fluoroscopy time and showed a trend toward reduced radiation doses.
Conclusion:US-AVA is a safe and effective technique for CIED lead implantation in Korean patients, with advantages over FL-AVA in terms of procedural efficiency and patient safety.
